Structure of granzyme C reveals an unusual mechanism of protease autoinhibition

Proteases act in important homeostatic pathways and are tightly regulated. Here, we report an unusual structural mechanism of regulation observed by the 2.5-Å X-ray crystal structure of the serine protease, granzyme C. Although the active-site triad residues adopt canonical conformations, the oxyanion hole is improperly formed, and access to the primary specificity (S1) pocket is blocked through a reversible rearrangement involving Phe-191. Specifically, a register shift in the 190-strand preceding the active-site serine leads to Phe-191 filling the S1 pocket. Mutation of a unique Glu–Glu motif at positions 192–193 unlocks the enzyme, which displays chymase activity, and proteomic analysis confirms that activity of the wild-type protease can be released through interactions with an appropriate substrate. The 2.5-Å structure of the unlocked enzyme reveals unprecedented flexibility in the 190-strand preceding the active-site serine that results in Phe-191 vacating the S1 pocket. Overall, these observations describe a broadly applicable mechanism of protease regulation that cannot be predicted by template-based modeling or bioinformatic approaches alone.

[1]  S. Maurer-Stroh,et al.  Analysis of Protein Processing by N-terminal Proteomics Reveals Novel Species-specific Substrate Determinants of Granzyme B Orthologs *S , 2009, Molecular & Cellular Proteomics.

[2]  Lianfa Shi,et al.  Human and mouse granzyme A induce a proinflammatory cytokine response. , 2008, Immunity.

[3]  Fei Long,et al.  ARP/wARP and molecular replacement: the next generation , 2007, Acta crystallographica. Section D, Biological crystallography.

[4]  A. Rosen,et al.  Granzyme H destroys the function of critical adenoviral proteins required for viral DNA replication and granzyme B inhibition , 2007, The EMBO journal.

[5]  J. Weitz,et al.  In the presence of phospholipids, glycosaminoglycans potentiate factor Xa-mediated protein C activation by modulating factor Xa activity. , 2007, Biochemistry.

[6]  L. Hellman,et al.  Expression profile of novel members of the rat mast cell protease (rMCP)-2 and (rMCP)-8 families, and functional analyses of mouse mast cell protease (mMCP)-8 , 2007, Immunogenetics.

[7]  J. Whisstock,et al.  The major human and mouse granzymes are structurally and functionally divergent , 2006, The Journal of cell biology.

[8]  Wei Li,et al.  Crystal structure of wild-type human thrombin in the Na+-free state. , 2005, The Biochemical journal.

[9]  Leszek Rychlewski,et al.  FFAS03: a server for profile–profile sequence alignments , 2005, Nucleic Acids Res..

[10]  N. Grishin,et al.  Three-dimensional structure of the rSly1 N-terminal domain reveals a conformational change induced by binding to syntaxin 5. , 2005, Journal of molecular biology.

[11]  E. Di Cera,et al.  Thrombin: A paradigm for enzymes allosterically activated by monovalent cations , 2004, Comptes rendus biologies.

[12]  P. Emsley,et al.  Coot: model-building tools for molecular graphics. , 2004, Acta crystallographica. Section D, Biological crystallography.

[13]  Randy J Read,et al.  Simple algorithm for a maximum-likelihood SAD function. , 2004, Acta crystallographica. Section D, Biological crystallography.

[14]  J. Trapani,et al.  Granzyme B Encoded by the Commonly Occurring Human RAH Allele Retains Pro-apoptotic Activity* , 2004, Journal of Biological Chemistry.

[15]  X. Puente,et al.  Human and mouse proteases: a comparative genomic approach , 2003, Nature Reviews Genetics.

[16]  S. Korsmeyer,et al.  Cell death induced by granzyme C. , 2003, Blood.

[17]  K. Gevaert,et al.  Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides , 2003, Nature Biotechnology.

[18]  Brian F. Volkman,et al.  Structure of a transiently phosphorylated switch in bacterial signal transduction , 2000, Nature.

[19]  J. Whisstock,et al.  Expression and purification of recombinant human granzyme B from Pichia pastoris. , 1999, Biochemical and biophysical research communications.

[20]  J. Goldberg,et al.  Structural Basis for Activation of ARF GTPase Mechanisms of Guanine Nucleotide Exchange and GTP–Myristoyl Switching , 1998, Cell.

[21]  C. Kelly,et al.  Nephritogenic T cells use granzyme C as a cytotoxic mediator , 1997, European journal of immunology.

[22]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[23]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[24]  J. Tschopp,et al.  Human and murine cytotoxic T lymphocyte serine proteases: subsite mapping with peptide thioester substrates and inhibition of enzyme activity and cytolysis by isocoumarins. , 1991, Biochemistry.

[25]  J. Tschopp,et al.  Granzymes, a Family of Serine Proteases Released from Granules of Cytolytic T Lymphocytes upon T Cell Receptor Stimulation , 1988, Immunological reviews.

[26]  G. Plaetinck,et al.  cDNA cloning of granzyme C, a granule-associated serine protease of cytolytic T lymphocytes. , 1988, Journal of immunology.

[27]  P. W. Tucker,et al.  Mechanism of charge compensation and impairment of co-operative functions in haemoglobin Tacoma (Arg B12(30)β → ser) , 1977 .

[28]  R. Huber,et al.  Crystal structure of bovine trypsinogen at 1-8 A resolution. II. Crystallographic refinement, refined crystal structure and comparison with bovine trypsin. , 1977, Journal of molecular biology.

[29]  D. Kirchhofer,et al.  New insight into how tissue factor allosterically regulates factor VIIa. , 2002, Trends in cardiovascular medicine.

[30]  A. Brünger.  Assessment of phase accuracy by cross validation: the free R value. Methods and applications. , 1993, Acta crystallographica. Section D, Biological crystallography.

[31]  W. G. Madow,et al.  Methods and applications , 1953 .